Trophoblast glycoprotein: Possible candidate mediating podocyte injuries in glomerulonephritis

American Journal of Nephrology

Volumn 32, Issue 6, 2010, Pages 505-521

  Murakami, Taichi ^a   Abe, Hideharu ^a,e   Nagai, Kojiro ^a   Tominaga, Tatsuya ^a   Takamatsu, Norimichi ^b   Araoka, Toshikazu ^a   Kishi, Seiji ^a   Takahashi, Toshikazu ^a   Mima, Akira ^a   Takai, Yoshimi ^c   Kopp, Jeffrey B ^d   Doi, Toshio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e NONE   (Japan)

Author keywords

Cell motility; Podocyte; Stress fiber; Thy1 glomerulonephritis; Transforming growth factor ; Trophoblast glycoprotein

Indexed keywords

CYTOCHALASIN D; GLYCOPROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; TROPHOBLAST GLYCOPROTEIN; UNCLASSIFIED DRUG; VINCULIN;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL DIFFERENTIATION; CELL MOTILITY; CYTOSKELETON; DEPOLYMERIZATION; FOCAL ADHESION; GENETIC TRANSFECTION; GLOMERULONEPHRITIS; IMMUNOFLUORESCENCE; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PATHOLOGY; PHENOTYPE; PODOCYTE INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; STRESS FIBER; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; CELLS, CULTURED; FOCAL ADHESIONS; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; ISOANTIBODIES; KIDNEY GLOMERULUS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MODELS, ANIMAL; PODOCYTES; RATS; RATS, WISTAR; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; STRESS FIBERS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 77958492409     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321366     Document Type: Article

References (36)

1. Kriz W, LeHir M: Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 2005; 67: 404-419.
2. Hara M, Yanagihara T, Takada T, Itoh M, Matsuno M, Yamamoto T, Kihara I: Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis. Am J Nephrol 1998; 18: 35-41.
3. Morioka Y, Koike H, Ikezumi Y, Ito Y, Oyanagi A, Gejyo F, Shimizu F, Kawachi H: Podocyte injuries exacerbate mesangial proliferative glomerulonephritis. Kidney Int 2001; 60: 2192-2204.
4. Yu D, Petermann A, Kunter U, Rong S, Shankland SJ, Floege J: Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol 2005; 16: 1733-1741.
5. Kriz W, Hackenthal E, Nobiling R, Sakai T, Elger M, Hahnel B: A role for podocytes to counteract capillary wall distension. Kidney Int 1994; 45: 369-376.
6. Lai KN, Leung JC, Chan LY, Saleem MA, Mathieson PW, Tam KY, Xiao J, Lai FM, Tang SC: Podocyte injury induced by mesangialderived cytokines in IgA nephropathy. Nephrol Dial Transplant 2009; 24: 62-72.
7. Campean V, Karpe B, Haas C, Atalla A, Peters H, Rupprecht H, Liebner S, Acker T, Plate K, Amann K: Angiopoietin 1 and 2 gene and protein expression is differentially regulated in acute anti-thy1.1 glomerulonephritis. Am J Physiol Renal Physiol 2008; 294:F1174-F1184.
8. Hole N, Stern PL: A 72 kD trophoblast glycoprotein defined by a monoclonal antibody. Br J Cancer 1988; 57: 239-246.
9. Southall PJ, Boxer GM, Bagshawe KD, Hole N, Bromley M, Stern PL: Immunohistological distribution of 5T4 antigen in normal and malignant tissues. Br J Cancer 1990; 61: 89-95.
10. Myers KA, Rahi-Saund V, Davison MD, Young JA, Cheater AJ, Stern PL: Isolation of a cDNA encoding 5T4 oncofetal trophoblast glycoprotein. An antigen associated with metastasis contains leucine-rich repeats. J Biol Chem 1994; 269: 9319-9324.
11. Carsberg CJ, Myers KA, Evans GS, Allen TD, Stern PL: Metastasis- associated 5T4 oncofoetal antigen is concentrated at microvillus projections of the plasma membrane. J Cell Sci 1995; 108: 2905-2916.
12. Carsberg CJ, Myers KA, Stern PL: Metastasis-associated 5T4 antigen disrupts cell-cell contacts and induces cellular motility in epithelial cells. Int J Cancer 1996; 68: 84-92.
13. Ward CM, Barrow K, Woods AM, Stern PL: The 5T4 oncofoetal antigen is an early differentiation marker of mouse ES cells and its absence is a useful means to assess pluripotency. J Cell Sci 2003; 116: 4533-4542.
14. Ward CM, Eastham AM, Stern PL: Cell surface 5T4 antigen is transiently upregulated during early human embryonic stem cell differentiation: effect of 5T4 phenotype on neural lineage formation. Exp Cell Res 2006; 312: 1713-1726.
15. Eastham AM, Spencer H, Soncin F, Ritson S, Merry CL, Stern PL, Ward CM: Epithelialmesenchymal transition events during human embryonic stem cell differentiation. Cancer Res 2007; 67: 11254-11262.
16. Edlund S, Landstrom M, Heldin CH, Aspenstrom P: Transforming growth factor-betainduced mobilization of actin cytoskeleton requires signaling by small GTPases Cdc42 and RhoA. Mol Biol Cell 2002; 13: 902-914.
17. Bakin AV, Safina A, Rinehart C, Daroqui C, Darbary H, Helfman DM: A critical role of tropomyosins in TGF-beta regulation of the actin cytoskeleton and cell motility in epithelial cells. Mol Biol Cell 2004; 15: 4682-4694.
18. Luimula P, Ahola H, Wang SX, Solin ML, Aaltonen P, Tikkanen I, Kerjaschki D, Holthofer H: Nephrin in experimental glomerular disease. Kidney Int 2000; 58: 1461-1468.
19. Doublier S, Salvidio G, Lupia E, Ruotsalainen V, Verzola D, Deferrari G, Camussi G: Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 2003; 52: 1023-1030.
20. Han GD, Koike H, Nakatsue T, Suzuki K, Yoneyama H, Narumi S, Kobayashi N, Mundel P, Shimizu F, Kawachi H: IFN-inducible protein-10 has a differential role in podocyte during Thy 1.1 glomerulonephritis. J Am Soc Nephrol 2003; 14: 3111-3126.
21. Sawai K, Mukoyama M, Mori K, Kasahara M, Koshikawa M, Yokoi H, Yoshioka T, Ogawa Y, Sugawara A, Nishiyama H, Yamada S, Kuwahara T, Saleem MA, Shiota K, Ogawa O, Miyazato M, Kangawa K, Nakao K: Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney. Am J Physiol Renal Physiol 2007; 293:F1363-F1372.
22. Endlich N, Kress KR, Reiser J, Uttenweiler D, Kriz W, Mundel P, Endlich K: Podocytes respond to mechanical stress in vitro. J Am Soc Nephrol 2001; 12: 413-422.
23. Okuda S, Languino LR, Ruoslahti E, Border WA: Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 1990; 86: 453-462.
24. Starzynska T, Rahi V, Stern PL: The expression of 5T4 antigen in colorectal and gastric carcinoma. Br J Cancer 1992; 66: 867-869.
25. Togawa A, Miyoshi J, Ishizaki H, Tanaka M, Takakura A, Nishioka H, Yoshida H, Doi T, Mizoguchi A, Matsuura N, Niho Y, Nishimune Y, Nishikawa S, Takai Y: Progressive impairment of kidneys and reproductive organs in mice lacking Rho GDIalpha. Oncogene 1999; 18: 5373-5380.
26. Asanuma K, Yanagida-Asanuma E, Faul C, Tomino Y, Kim K, Mundel P: Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling. Nat Cell Biol 2006; 8: 485-491.
27. Sastry SK, Burridge K: Focal adhesions: a nexus for intracellular signaling and cytoskeletal dynamics. Exp Cell Res 2000; 261: 25-36.
28. Kreidberg JA: Functions of alpha3beta1 integrin. Curr Opin Cell Biol 2000; 12: 548-553.
29. Teixeira Vde P, Blattner SM, Li M, Anders HJ, Cohen CD, Edenhofer I, Calvaresi N, Merkle M, Rastaldi MP, Kretzler M: Functional consequences of integrin-linked kinase activation in podocyte damage. Kidney Int 2005; 67: 514-523.
30. Reiser J, Oh J, Shirato I, Asanuma K, Hug A, Mundel TM, Honey K, Ishidoh K, Kominami E, Kreidberg JA, Tomino Y, Mundel P: Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin l and alpha3 integrin. J Biol Chem 2004; 279: 34827-34832.
31. Kopp JB, Factor VM, Mozes M, Nagy P, Sanderson N, Bottinger EP, Klotman PE, Thorgeirsson SS: Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab Invest 1996; 74: 991-1003.
32. Schiffer M, Bitzer M, Roberts IS, Kopp JB, ten Dijke P, Mundel P, Bottinger EP: Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 2001; 108: 807-816.
33. Li Y, Kang YS, Dai C, Kiss LP, Wen X, Liu Y: Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 2008; 172: 299-308.
34. Somlo S, Mundel P: Getting a foothold in nephrotic syndrome. Nat Genet 2000; 24: 333-335.
35. Lee EY, Chung CH, Khoury CC, Yeo TK, Pyagay PE, Wang A, Chen S: The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability. Am J Physiol Renal Physiol 2009; 297:F85-F94.
36. Wei C, Moller CC, Altintas MM, Li J, Schwarz K, Zacchigna S, Xie L, Henger A, Schmid H, Rastaldi MP, Cowan P, Kretzler M, Parrilla R, Bendayan M, Gupta V, Nikolic B, Kalluri R, Carmeliet P, Mundel P, Reiser J: Modification of kidney barrier function by the urokinase receptor. Nat Med 2008; 14: 55-63.